Advertisement
David Smith, executive vice president and chief financial officer, willprovide an update on the company, beginning at 4:25 p.m., Eastern DaylightTime (1:25 p.m., Pacific Daylight Time).
Advertisement
The presentation will be available through the conference website athttp://www.veracast.com/webcasts/twp/healthcare07/23115282.cfm and on thecompany's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heartfailure. The company's product lines include the Thoratec(R) VAD (VentricularAssist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) withmore than 11,000 devices implanted in patients suffering from heart failure.Additionally, its International Technidyne Corporation (ITC) division suppliesblood testing and skin incision products. Thoratec is headquartered inPleasanton, California. For more information, visit the company's websites athttp://www.thoratec.com or http://www.itcmed.com
TNR-455
SOURCE Thoratec Corporation
